Abstract
Cotinine is a proxy for secondhand smoke (SHS) exposure. Genetic variation along nicotine and cotinine metabolic pathways may alter the internal cotinine dose, leading to misinterpretations of exposure-health outcome associations. Caucasian children with available SHS exposure and hair cotinine data were genotyped for metabolism-related genes. SHS-exposed children had 2.4-fold higher hair cotinine (0.14±0.22 ng mg-1) than unexposed children (0.06±0.05 ng mg-1, P<0.001). SHS-exposed children carrying the NAT1 minor allele had twofold higher hair cotinine (0.18 ng mg-1 for heterozygotes and 0.17 ng mg-1 for homozygotes) compared with major allele homozygotes (0.09 ng mg-1, P=0.0009), even after adjustment for SHS dose. These findings support that NAT1 has a role in the metabolic pathway of nicotine/cotinine and/or their metabolites. The increased cotinine levels observed for those carrying the minor allele may lead to SHS exposure misclassification in studies utilizing cotinine as a biomarker. Additional studies are required to identify functional single-nucleotide polymorphism(s) (SNP(s)) in NAT1 and elucidate the biological consequences of the mutation(s).
Original language | English |
---|---|
Pages (from-to) | 189-195 |
Number of pages | 7 |
Journal | Pharmacogenomics Journal |
Volume | 15 |
Issue number | 2 |
DOIs | |
State | Published - 25 Apr 2015 |
Externally published | Yes |